Screener
Indivior Pharmaceuticals, Inc. INDV Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Goodwill and other intangible assets, net | 2 | 2 |
| Deferred tax assets | 296 | 323 |
| Other noncurrent assets | 26 | 27 |
| Total assets | $1,197 | $1,201 |
| Liabilities and stockholders' deficit | ||
| Current liabilities | ||
| Accrued rebates and product returns | $551 | $582 |
| Accounts payable and accrued expenses | 178 | 250 |
Item 1. Unaudited Condensed Financial Statements.
FAQ
- What is Indivior Pharmaceuticals, Inc.'s total assets?
- Indivior Pharmaceuticals, Inc. (INDV) reported total assets of $1.2B in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s total assets decreased by 12.9% year-over-year, from $1.38B to $1.2B.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s total assets?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc.'s total assets has grown at a -17.3% compound annual growth rate (CAGR), from $1.76B to $1.2B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Indivior Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude